BRD9185 is primarily utilized in research settings to study its potential as an inhibitor of specific biological pathways. It has shown promise in targeting and modulating certain enzymes or proteins involved in disease mechanisms, particularly in cancer and other proliferative disorders. Researchers are exploring its efficacy in preclinical models to understand its therapeutic potential and to assess its role in disrupting abnormal cellular processes. Additionally, it is being investigated for its selectivity and potency in inhibiting specific molecular targets, which could lead to the development of novel treatments for challenging medical conditions. Its application is currently confined to laboratory studies, with ongoing efforts to evaluate its safety and effectiveness for future clinical use.